Streetbeat News

Revenues

AEHR

Aehr Test Systems (NASDAQ:AEHR) stock fell after reporting Q2 earnings that beat estimates but lowering its full-year revenue guidance due to a slowdown in the electric vehicle market and shifts in customer product mix. The company now expects full-year 2024 revenue of $75 million to $85 million, a growth of 15% to 30%. AEHR shares dropped 18.6% to $18.19.

Portfolio Pulse from Adam Eckert

January 10, 2024 | 2:10 pm

RCEL

AVITA Medical anticipates Q1 commercial revenue to be between $14.8M and $15.6M, and forecasts FY24 commercial revenue to range from $79.5M to $84.5M.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 2:08 pm

RCEL

AVITA Medical announced preliminary commercial revenue of approximately $14.1 million for Q4 and $49.8 million for the full fiscal year 2023. These figures have not been finalized and are subject to change upon completion of the company's financial closing procedures.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 2:08 pm

TSM

TSMC reported a decrease in revenue for December, with a 14.4% drop from November and an 8.4% year-over-year decline, totaling approximately NT$176.30 billion.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 2:05 pm

GDRX

GoodRx has announced preliminary adjusted revenue for FY23 to be between $759M-$761M, surpassing the consensus estimate of $744.26M.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 2:04 pm

GDRX

GoodRx has announced preliminary Q4 adjusted revenue figures of $195M-$197M, surpassing the estimated $190.77M. This positive financial news could indicate a stronger performance than expected for the company.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 2:03 pm

ETWO

E2open Parent Holdings Inc (NYSE:ETWO) shares increased by approximately 11% in premarket trading following the release of their Q3 FY24 results. The company reported a slight revenue decline of 4.5% year-over-year to $157.5 million, which still beat the consensus estimate of $154.3 million. GAAP subscription revenue decreased by 1.5% year-over-year to $132.8 million. Adjusted gross profit and EBITDA also saw declines, but the company maintained or improved margins compared to the previous year. Adjusted EPS met consensus estimates at $0.04. The company has adjusted its FY24 revenue guidance slightly and expects a modest organic growth in subscription revenue. CFO Marje Armstrong expressed confidence in the company's direction despite market uncertainties.

Portfolio Pulse from Lekha Gupta

January 10, 2024 | 2:03 pm

SEALSQ

SEALSQ announced preliminary financial results for FY23, expecting revenues to reach $30M. No mention of LAES in the context of these results.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 2:01 pm

CHRW

C.H. Robinson Worldwide (NASDAQ:CHRW) has been analyzed by 4 analysts, showing a consensus towards a bearish stance with 3 'Somewhat Bearish' and 1 'Indifferent' ratings. The average 12-month price target is $74.00, down from the previous $76.00. Analysts from JP Morgan, Susquehanna, Morgan Stanley, and Stifel have adjusted their price targets and ratings, reflecting changes in market conditions and company performance. Despite a -27.83% decline in revenue growth for the quarter ending September 30, 2023, CHRW maintains strong profitability indicators such as a net margin of 1.89%, ROE of 5.87%, and ROA of 1.53%, with a low debt-to-equity ratio of 1.39.

Portfolio Pulse from Benzinga Insights

January 10, 2024 | 2:01 pm

PFSI

PennyMac Financial Servs (NYSE:PFSI) has received diverse analyst ratings in the last three months, with the most recent showing increased bullish sentiment. The average 12-month price target for PFSI is now $94.67, up from $86.00, with a high estimate of $115.00 and a low of $82.00. Analysts from Deutsche Bank, Wedbush, Keefe, Bruyette & Woods, UBS, Barclays, and Piper Sandler have provided updates, with most raising their price targets. PFSI operates in mortgage lending and investment management, with a strong market capitalization, net margin, ROE, and ROA, but has faced revenue challenges with a slight decline over the past 3 months.

Portfolio Pulse from Benzinga Insights

January 10, 2024 | 2:01 pm